~~<i id='2DB908CE95'><strike id='2DB908CE95'><tt id='2DB908CE95'><pre id='2DB908CE95'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：explore 2025-09-30 03:00:05 Page View：636

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Scientists inch closer to single
Next article： Sports medicine is finally prioritizing gender equality

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

Physician groups backed by private equity giant lobby on mergers

PhysiciangroupsbackedbyWelsh,Carson,Anderson&Stowearelookingtoinfluencefederalmergerpolicy.Adobe

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Iran'sPresidentEbrahimRaisi,center,andKenya'sPresidentWilliamRuto,right,arrivetogiveajointpressconfe

WSS

focus

focus

knowledge

leisure time

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'